Омнипак

Omnipaque (iohexol) is a non-ionic, low-osmolar contrast agent used in radiology for clear imaging during CT scans, angiography, and myelography. Suitable for intravenous, intraarterial, and intrathecal administration. Designed for enhanced visibility of blood vessels and soft tissues.

Omnipaque is used to improve the visibility of internal body structures during diagnostic imaging procedures. It is commonly employed in CT scans, angiographic studies, and myelograms to highlight blood vessels, organs, and the spinal canal. The contrast agent helps radiologists identify abnormalities such as blockages, tumors, or structural issues.

After administration, Omnipaque enhances the contrast of X-ray images, making it easier to distinguish between different tissues and structures. Patients may experience a warm sensation or metallic taste temporarily. Some individuals report mild discomfort at the injection site, which typically resolves quickly.

Omnipaque should be used with caution in patients with known allergies to iodinated contrast agents or severe kidney disease. Adequate hydration before and after the procedure is recommended to support kidney function. Inform your healthcare provider of any pre-existing conditions or medications.

Concomitant use of certain medications, such as metformin or nephrotoxic drugs, may require temporary discontinuation or monitoring. Alcohol consumption may increase the risk of adverse effects. Always disclose all medications and supplements to your healthcare provider before receiving Omnipaque.